Related Experiment Video
Updated: Aug 6, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Do older adults using NSAIDs have a reduced risk of colorectal cancer?
Michael Hoffmeister1, Jenny Chang-Claude, Hermann Brenner
1Department of Epidemiology, German Centre for Research on Ageing (DZFA), Heidelberg, Germany.
Background And Objectives:
Colorectal cancer (CRC) is primarily a disease of older adults. Although NSAIDs are thought to protect from CRC, and long-term use of NSAIDs is common in the elderly, little is known about the impact of NSAID use on CRC risk at advanced age. We specifically reviewed current evidence regarding the effects of NSAIDs on CRC risk in individuals aged > or =65 years, a rapidly growing age group.
Study Design:
We searched all articles in PubMed published before August 2005. Studies were included if a subgroup analysis of older adults (> or =65 years of age) was performed, or if long-term use of NSAIDs for > or =5 years and CRC risk was investigated. From the selected studies, relevant information, including sample characteristics and association with CRC risk, was extracted and compared.
Results:
Altogether 19 studies were identified. Only four studies specifically considered NSAID use in people > or =65 years of age; of these, two showed risk reduction for CRC comparable to that seen in younger age groups or in all age groups. The most informative observational studies found decreasing relative risk of CRC with increasing duration of NSAID use, suggesting substantial risk reduction after 10-20 years of regular use.
Conclusions:
The available data on long-term effects of NSAID use in elderly people are sparse but predominantly indicate risk reduction for CRC comparable to that seen in younger age groups or all ages. Whether and to what degree initiating NSAID use in old age prevents CRC is essentially unknown. In light of the potential adverse effects of NSAIDs, including recent data on adverse cardiovascular outcomes, more information is needed on the minimum effective dose of NSAIDs and the duration of use required in order to evaluate individual risks and benefits in older adults.
Insights
Long-term nonsteroidal anti-inflammatory drug (NSAID) use appears to reduce colorectal cancer (CRC) risk in older adults, similar to younger populations. However, initiating NSAID use in old age for CRC prevention requires further study due to potential risks.
Area of Science:
- Gerontology
- Gastroenterology
- Oncology
Background:
- Colorectal cancer (CRC) predominantly affects older adults.
- Nonsteroidal anti-inflammatory drug (NSAID) use is common in the elderly, but its impact on CRC risk in this age group is not well understood.
Purpose of the Study:
- To review current evidence on the effects of NSAID use on CRC risk in individuals aged 65 years and older.
- To assess the impact of long-term NSAID use on CRC risk in the elderly population.
Main Methods:
- Searched PubMed for articles published before August 2005.
- Included studies with subgroup analyses of individuals aged 65+ or investigating long-term NSAID use (≥5 years) and CRC risk.
- Extracted and compared relevant information on sample characteristics and CRC risk association.
Main Results:
- Identified 19 studies; only four specifically analyzed NSAID use in individuals aged 65+.
- Two of these four studies showed CRC risk reduction comparable to younger age groups.
- Observational studies indicated decreasing CRC risk with increasing NSAID duration, suggesting significant reduction after 10-20 years of regular use.
Conclusions:
- Available data suggest NSAID use may reduce CRC risk in the elderly, comparable to other age groups.
- The effectiveness of initiating NSAID use for CRC prevention in advanced age remains unknown.
- More research is needed on optimal NSAID dosage and duration for older adults, considering potential adverse effects like cardiovascular outcomes.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Cancer Prevention
Some...
Pharmacodynamics in Geriatric Patients: Effects of Age
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...